Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Discontinuing statins near the end of life is safe, improves patient quality of life

2014 ASCO Annual Meeting

30 May - 3 Jun 2014

Published: 2 Jun 2014

Views: 2650

Rating:

Save

Prof Amy P. Abernethy - Duke University School of Medicine, Durham, USA

Prof Abernethy talks to ecancertv at ASCO 2014 about the new findings from a federally funded randomised study which indicate that it is safe to stop statin therapy in patients with a life expectancy of less than a year.

Read the article for more.

Related Videos

Gaza's cancer patients: Navigating the dual struggle of illness and war

Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America

Gaza's cancer patients: Navigating the dual struggle of illness and war ( Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America )

Cancer in emergencies: What can we do better to protect the most vulnerable?

Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara...

Cancer in emergencies: What can we do better to protect the most vulnerable? ( Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara, Turkey )

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale...

ESMO and WCLC: Latest developments in EGFR mutated NSCLC ( Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale Tomasini )

Grand Rounds: Improving quality of patient-centred care

Dr Didier Verhoeven, Prof Nirmala Bhoo Pathy and Dr Luzia Travado

Grand Rounds: Improving quality of patient-centred care ( Dr Didier Verhoeven, Prof Nirmala Bhoo Pathy and Dr Luzia Travado )

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

The Southeast Asian Breast Cancer Symposium; background, aims and successes

Carolyn Taylor - Executive Director, Global Focus on Cancer

The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )

The current status of multiple myeloma diagnosis and treatment

Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina

The current status of multiple myeloma diagnosis and treatment ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )

Hypofractionated high dose intensity modulated radiotherapy non-inferior for...

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK

$Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )$

Cancer pain management

Prof Ebtesam Ahmed - St John's University New York, New York City, USA

Cancer pain management ( Prof Ebtesam Ahmed - St John's University New York, New York City, USA )

More from ecancer